Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diane Rushlow

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Human Mutation|January 9, 2008
Patterns of missplicing caused by RB1 gene mutations in patients with retinoblastoma and association with phenotypic expressionKatherine Zhang, Inga Nowak, Diane Rushlow, et al.
Journal of Medical Genetics|March 19, 2011
Identification of clinically relevant mosaicism in type I hereditary haemorrhagic telangiectasiaNadia Prigoda Lee, Donco Matevski, Daniela Dumitru, et al.
Familial Cancer|May 30, 2008
Identification of a mutation in exon 27 of the RB1 gene associated with incomplete penetrance retinoblastomaDiana Mitter, Diane Rushlow, Inga Nowak, et al.
Human Mutation|February 16, 2005
Novel mutations and polymorphisms in genes causing hereditary hemorrhagic telangiectasiaSalma A Abdalla, Urszula Cymerman, Diane Rushlow, et al.
Human Mutation|March 13, 2009
Detection of mosaic RB1 mutations in families with retinoblastomaDiane Rushlow, Beata Piovesan, Katherine Zhang, et al.
International Journal of Cancer|January 6, 2007
Human retinoblastoma is not caused by known pRb-inactivating human DNA tumor virusesMaura L Gillison, Renwei Chen, Eleni Goshu, et al.
Pathology, Research and Practice|December 20, 2011
Needle core biopsies provide ample material for genomic and proteomic studies of kidney cancer: observations on DNA, RNA, protein extractions and VHL mutation detectionGhada Kurban, Brenda L Gallie, Michael Leveridge, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|July 15, 2010
Using RB1 mutations to assess minimal residual disease in metastatic retinoblastomaHelen Dimaras, Diane Rushlow, William Halliday, et al.
Cancer Genetics|June 20, 2016
Molecular analysis distinguishes metastatic disease from second cancers in patients with retinoblastomaHilary Racher, Sameh Soliman, Bob Argiropoulos, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Human Mutation|January 9, 2008
Patterns of missplicing caused by RB1 gene mutations in patients with retinoblastoma and association with phenotypic expressionKatherine Zhang, Inga Nowak, Diane Rushlow, et al.
Journal of Medical Genetics|March 19, 2011
Identification of clinically relevant mosaicism in type I hereditary haemorrhagic telangiectasiaNadia Prigoda Lee, Donco Matevski, Daniela Dumitru, et al.
Familial Cancer|May 30, 2008
Identification of a mutation in exon 27 of the RB1 gene associated with incomplete penetrance retinoblastomaDiana Mitter, Diane Rushlow, Inga Nowak, et al.
Human Mutation|February 16, 2005
Novel mutations and polymorphisms in genes causing hereditary hemorrhagic telangiectasiaSalma A Abdalla, Urszula Cymerman, Diane Rushlow, et al.
Human Mutation|March 13, 2009
Detection of mosaic RB1 mutations in families with retinoblastomaDiane Rushlow, Beata Piovesan, Katherine Zhang, et al.
International Journal of Cancer|January 6, 2007
Human retinoblastoma is not caused by known pRb-inactivating human DNA tumor virusesMaura L Gillison, Renwei Chen, Eleni Goshu, et al.
Pathology, Research and Practice|December 20, 2011
Needle core biopsies provide ample material for genomic and proteomic studies of kidney cancer: observations on DNA, RNA, protein extractions and VHL mutation detectionGhada Kurban, Brenda L Gallie, Michael Leveridge, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|July 15, 2010
Using RB1 mutations to assess minimal residual disease in metastatic retinoblastomaHelen Dimaras, Diane Rushlow, William Halliday, et al.
Cancer Genetics|June 20, 2016
Molecular analysis distinguishes metastatic disease from second cancers in patients with retinoblastomaHilary Racher, Sameh Soliman, Bob Argiropoulos, et al.
Pageof 1